Saturday, August 2, 2025 8/2/2025

Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing

Award Number: R33DA054819
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/15/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2027

Group Awards By:

View Award Description

Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing - PROJECT SUMMARY Cocaine use disorder represents a major public health challenge, and novel treatment approaches are urgently needed. Tobacco usage is highly co-morbid with cocaine use disorder, and at present, it is not known whether/how nicotinic signal transduction modulates the brain's response to cocaine. We hypothesize that tobacco usage contributes to cocaine use, and we will model this research question using a rat model system. We will probe the mechanistic underpinnings of nicotinic modulation of cocaine reinforcement, focusing on identifying key nicotine receptors and nerve cell types in the brain's reward circuit. In the R21 phase, we will validate a set of molecular tools that we developed in a previously funded project. These tools allow us to reduce or eliminate the expression of specific nicotine receptors in precise cell types in the brain. We'll verify that these tools work for their purpose in this project, examining how well they reduce nicotine receptor function in cellular assays (Aim 1). This involves single-cell patch-clamp recordings and fiber photometry. In R21 Aim 2, we will determine whether/how nicotine receptor functional attenuation impacts cocaine self-administration behavior. Specific manipulations that impact cocaine reinforcement will be confirmed with replication studies and other control experiments then advanced to the R33 phase for further investigation. In the R33, we will further probe the mechanisms by which nicotine receptors modulate cocaine reinforcement. R33 Aim 3 will probe the circuits involved in nicotine receptor modulation of cocaine self-administration. R33 Aim 4 will use a biophysical approach to examine the novel hypothesis that cocaine has direct acute and long-term interactions with nicotine receptors. Together, these AIMs will help us understand how nicotine receptor activity modulates cocaine intake. Associated neurobiological mechanisms will be identified, potentially leading to novel approaches to treat tobacco and/or cocaine dependence.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $380,464 )
2025	2025	WAKE FOREST UNIVERSITY HEALTH SCIENCES	MEDICAL CENTER BLVD	WINSTON SALEM	NC	27157	FORSYTH	USA	Drug Use and Addiction Research Programs	001	3	12/24/2024	EXTENSION WITH OR WITHOUT FUNDS	$4
2025	2025	WAKE FOREST UNIVERSITY HEALTH SCIENCES	MEDICAL CENTER BLVD	WINSTON SALEM	NC	27157	FORSYTH	USA	Drug Use and Addiction Research Programs	000	3	11/8/2024	EXTENSION WITH OR WITHOUT FUNDS	$380,460
														Subtotal = $380,464

Grand Total All Awards = $380,464

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cholinergic mechanisms of cocaine reinforcement probed with nicotinic receptor gene editing

Award Number: R33DA054819

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/15/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer